Need Help? Chat Now With a Live Representative!

ARG To Attend JPM Health Care Conference in January

ARG To Attend JPM Health Care Conference in January

ARG To Attend JPM Health Care Conference in January

December 8, 2022

The 41st Annual J.P. Morgan Health Care Conference will take place January 9-12, 2023 in San Francisco, CA. Mike Baker, Senior Vice President of Business Development, will once again be representing ARG at the event.

This is the official description: “This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.”

When asked why the meeting is so vital to global drug development, Mike said, “It’s the one time each year everyone in biotech is in the same place. Emerging trends are presented, setting the stage for biotech advancements for the year. There are thousands of people in a four-block radius. The organized chaos leads to meaningful interactions-- both pre-planned and impromptu meetings.”

MIke followed up by explaining why the conference is important for ARG: “First, we get a chance to connect with current customers. In addition, we get to meet potential partners and hear about their visions. Beyond that, JPM is a great launchpad for awareness about ARG and our focus on oncology, neurology and immunology.”

ARG is aligned with the vision of the JPM Health Care Conference by driving to get better every day. We challenge each of our functional service groups to uphold our organizational reputation of being tangibly better than other CROs. Each service must be forward-thinking and adaptive. ARG’s differentiation is evident in everything we do.

Please contact Mike at mbaker@atlanticresearchgroup.com to arrange a discussion in San Francisco.

The Vital Role of Team Stability in Advancing Clinical Trials

The Vital Role of Team Stability in Advancing Clinical Trials

In the fast-paced world of clinical research, turnover rates are high and project continuity can be a challenge. However, at […]

March 29, 2024
Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
GO TO TOP